Beam Therapeutics (BEAM) Stock Price & Financial Analysis
Beam Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Beam Therapeutics
What is the current stock price for BEAM?
As of the latest trading session, BEAM stock trades at $34.14. The 52-week range is $15.60–$36.44, with a day range of $32.66–$34.35.
What is the P/E ratio for BEAM?
The P/E ratio (Price-to-Earnings) for BEAM is shown in the Key Statistics section. This valuation metric helps compare Beam Therapeutics Inc. to industry peers.
Does BEAM pay dividends?
Beam Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for BEAM?
Based on 12 analysts, the consensus for BEAM is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of BEAM?
Beam Therapeutics's market capitalization is $3.53B, classifying it as a mid-cap company. Beam Therapeutics operates in the Healthcare sector within the Biotechnology industry.